Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Schiff

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Rheumatology and Therapy|September 29, 2017
Chronic Disease and Self-Injection: Ethnographic Investigations into the Patient Experience During TreatmentMichael Schiff, Shane Saunderson, Irina Mountian, et al.
Current Medical Research and Opinion|May 1, 2010
Effect of maximum OTC doses of naproxen sodium or acetaminophen on low-dose aspirin inhibition of serum thromboxane B2John Oldenhof, Marc Hochberg, Michael Schiff, et al.
The Plant Journal : for Cell and Molecular Biology|September 11, 2002
Virus-induced gene silencing in tomatoYule Liu, Michael Schiff, S P Dinesh-Kumar
The Plant Journal : for Cell and Molecular Biology|May 18, 2004
Involvement of MEK1 MAPKK, NTF6 MAPK, WRKY/MYB transcription factors, COI1 and CTR1 in N-mediated resistance to tobacco mosaic virusYule Liu, Michael Schiff, S P Dinesh-Kumar
Expert Review of Medical Devices|June 18, 2014
New autoinjector technology for the delivery of subcutaneous methotrexate in the treatment of rheumatoid arthritisMichael Schiff, Jonathan Jaffe, Bruce Freundlich, et al.
Clinical Drug Investigation|July 15, 2010
Mycophenolate mofetil in the treatment of adults with advanced rheumatoid arthritis: three 24-week, randomized, double-blind, placebo- or ciclosporin-controlled trialsMichael Schiff, Andre Beaulieu, David L Scott, et al.
Current Medical Research and Opinion|August 15, 2009
Platelet inhibitory effects of OTC doses of naproxen sodium compared with prescription dose naproxen sodium and low-dose aspirinMichael Schiff, Marc C Hochberg, John Oldenhof, et al.
Digestive Diseases and Sciences|October 17, 2003
Fatal cholestatic liver failure associated with gemcitabine therapyKeith Robinson, Louis Lambiase, Jianjun Li, et al.
Expert Opinion on Drug Delivery|April 3, 2020
A multicenter, open-label study to evaluate the safe and effective use of a new electromechanical auto-injection device for self-injection of certolizumab pegolDaljit Tatla, Irina Mountian, Boglarka Szegvari, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2016
Brief Report: Estimating Disease Activity Using Multi-Biomarker Disease Activity Scores in Rheumatoid Arthritis Patients Treated With Abatacept or AdalimumabRoy Fleischmann, Sean E Connolly, Michael A Maldonado, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Rheumatology and Therapy|September 29, 2017
Chronic Disease and Self-Injection: Ethnographic Investigations into the Patient Experience During TreatmentMichael Schiff, Shane Saunderson, Irina Mountian, et al.
Current Medical Research and Opinion|May 1, 2010
Effect of maximum OTC doses of naproxen sodium or acetaminophen on low-dose aspirin inhibition of serum thromboxane B2John Oldenhof, Marc Hochberg, Michael Schiff, et al.
The Plant Journal : for Cell and Molecular Biology|September 11, 2002
Virus-induced gene silencing in tomatoYule Liu, Michael Schiff, S P Dinesh-Kumar
The Plant Journal : for Cell and Molecular Biology|May 18, 2004
Involvement of MEK1 MAPKK, NTF6 MAPK, WRKY/MYB transcription factors, COI1 and CTR1 in N-mediated resistance to tobacco mosaic virusYule Liu, Michael Schiff, S P Dinesh-Kumar
Expert Review of Medical Devices|June 18, 2014
New autoinjector technology for the delivery of subcutaneous methotrexate in the treatment of rheumatoid arthritisMichael Schiff, Jonathan Jaffe, Bruce Freundlich, et al.
Clinical Drug Investigation|July 15, 2010
Mycophenolate mofetil in the treatment of adults with advanced rheumatoid arthritis: three 24-week, randomized, double-blind, placebo- or ciclosporin-controlled trialsMichael Schiff, Andre Beaulieu, David L Scott, et al.
Current Medical Research and Opinion|August 15, 2009
Platelet inhibitory effects of OTC doses of naproxen sodium compared with prescription dose naproxen sodium and low-dose aspirinMichael Schiff, Marc C Hochberg, John Oldenhof, et al.
Digestive Diseases and Sciences|October 17, 2003
Fatal cholestatic liver failure associated with gemcitabine therapyKeith Robinson, Louis Lambiase, Jianjun Li, et al.
Expert Opinion on Drug Delivery|April 3, 2020
A multicenter, open-label study to evaluate the safe and effective use of a new electromechanical auto-injection device for self-injection of certolizumab pegolDaljit Tatla, Irina Mountian, Boglarka Szegvari, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2016
Brief Report: Estimating Disease Activity Using Multi-Biomarker Disease Activity Scores in Rheumatoid Arthritis Patients Treated With Abatacept or AdalimumabRoy Fleischmann, Sean E Connolly, Michael A Maldonado, et al.
Pageof 9